UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023622
Receipt number R000027205
Scientific Title Molecular alterations and clinicopathological features in sporadic duodenal adenocarcinoma
Date of disclosure of the study information 2016/08/15
Last modified on 2019/08/16 16:06:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Molecular alterations and clinicopathological features in sporadic duodenal adenocarcinoma

Acronym

Molecular alterations in duodenal adenocarcinoma

Scientific Title

Molecular alterations and clinicopathological features in sporadic duodenal adenocarcinoma

Scientific Title:Acronym

Molecular alterations in duodenal adenocarcinoma

Region

Japan


Condition

Condition

Primary extra-ampullary duodenal adenocarcinoma

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

YES


Objectives

Narrative objectives1

To clarify the molecular alterations in duodenal adenocarcinoma

Basic objectives2

Others

Basic objectives -Others

To clarify the association between clinicopathological features including mucin phenotype and molecular alterations in duodenal adenocarcinoma

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Molecular analyses in duodenal adenocarcinoma

Key secondary outcomes

Association between clinicopathological features including mucin phenotype and molecular alterations in duodenal adenocarcinoma


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Primary extra-ampullary duodenal adenocarcinoma

Key exclusion criteria

1) Patients with a known familial cancer syndrome including familial adenomatous polyposis
2) Patients who have determined by
the physicians to have any reasons of unqualified

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Hiroto
Middle name
Last name Miwa

Organization

Hyogo College of Medicine

Division name

Division of Gastroenterology, Department of Internal Medicine

Zip code

663-8501

Address

1-1, Mukogawa-cho, Nishinomiya

TEL

0798-45-6665

Email

miwahgi@hyo-med.ac.jp


Public contact

Name of contact person

1st name Jiro
Middle name
Last name Watari

Organization

Hyogo College of Medicine

Division name

Division of Gastroenterology, Department of Internal Medicine

Zip code

663-8501

Address

1-1, Mukogawa-cho, Nishinomiya

TEL

0798-45-6662

Homepage URL


Email

watarij@hyo-med.ac.jp


Sponsor or person

Institute

Hyogo College of Medicine,
Division of Gastroenterology, Department of Internal Medicine

Institute

Department

Personal name



Funding Source

Organization

Hyogo College of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Aichi Cancer Center Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hyogo College of Medicine

Address

1-1, Mukogawa-cho, Nishinomiya

Tel

0166-45-6662

Email

watarij@hyo-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 08 Month 15 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled

32

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 05 Month 20 Day

Date of IRB

2016 Year 03 Month 05 Day

Anticipated trial start date

2016 Year 05 Month 20 Day

Last follow-up date

2019 Year 01 Month 24 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2019 Year 01 Month 31 Day


Other

Other related information

No special instruction


Management information

Registered date

2016 Year 08 Month 14 Day

Last modified on

2019 Year 08 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027205


Research Plan
Registered date File name
2019/08/16 多施設共同特定臨床研究に対する補助事業研究計画書 Ver.8.doc

Research case data specifications
Registered date File name
2019/08/16 Watari_et_al-2019-Scientific_Reports.pdf

Research case data
Registered date File name
2019/08/16 Supplementary Figures and Tables.docx